| MeSH term | MeSH ID | Detail |
|---|---|---|
| Postgastrectomy Syndromes | D011178 | 2 associated lipids |
| Elephantiasis | D004604 | 2 associated lipids |
| Mastoiditis | D008417 | 2 associated lipids |
| Pityriasis Lichenoides | D017514 | 2 associated lipids |
| Herpes Genitalis | D006558 | 2 associated lipids |
| Ehrlichiosis | D016873 | 2 associated lipids |
| Hearing Loss, Functional | D006315 | 2 associated lipids |
| Onychomycosis | D014009 | 2 associated lipids |
| Tooth Fractures | D014082 | 2 associated lipids |
| Porphyrias | D011164 | 2 associated lipids |
erythromycin
erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.
Cross Reference
Introduction
To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with erythromycin?
erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (35)
- J. Antimicrob. Chemother. (18)
- J. Pharmacol. Exp. Ther. (2)
- Others (29)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with erythromycin
PubChem Associated disorders and diseases
What pathways are associated with erythromycin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with erythromycin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with erythromycin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with erythromycin?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with erythromycin?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (19)
- J. Antimicrob. Chemother. (10)
- Drug Metab. Dispos. (5)
- Others (29)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with erythromycin?
Mouse Model
Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).
Knock-out
Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with erythromycin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Liu X et al. | Potentials and mechanisms of genotoxicity of six pharmaceuticals frequently detected in freshwater environment. | 2012 | Toxicol. Lett. | pmid:22450446 |
| Sorensen EM and Acosta D | Erythromycin estolate-induced toxicity in cultured rat hepatocytes. | 1985 | Toxicol. Lett. | pmid:4060187 |
| Mazur CS et al. | P-glycoprotein inhibition by the agricultural pesticide propiconazole and its hydroxylated metabolites: Implications for pesticide-drug interactions. | 2015 | Toxicol. Lett. | pmid:25268938 |
| Montenez JP et al. | Interactions of macrolide antibiotics (Erythromycin A, roxithromycin, erythromycylamine [Dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models. | 1999 | Toxicol. Appl. Pharmacol. | pmid:10198278 |
| Mahgoub A et al. | Azithromycin and erythromycin ameliorate the extent of colonic damage induced by acetic acid in rats. | 2005 | Toxicol. Appl. Pharmacol. | pmid:15885263 |
| Gracia T et al. | Modulation of steroidogenic gene expression and hormone production of H295R cells by pharmaceuticals and other environmentally active compounds. | 2007 | Toxicol. Appl. Pharmacol. | pmid:17822730 |
| Gant TW et al. | In vivo induction of liver P-glycoprotein expression by xenobiotics in monkeys. | 1995 | Toxicol. Appl. Pharmacol. | pmid:7645023 |
| Fujii E et al. | Assessment of the carcinogenic potential of mitemcinal (GM-611): increased incidence of malignant lymphoma in a rat carcinogenicity study. | 2008 | Toxicol. Appl. Pharmacol. | pmid:18355581 |
| Dakhel Y and Jamali F | Erythromycin potentiates PR interval prolonging effect of verapamil in the rat: a pharmacodynamic drug interaction. | 2006 | Toxicol. Appl. Pharmacol. | pmid:16466760 |
| Gray JE et al. | Drug-induced enteropathy characterized by lipid in macrophages. | 1974 | Toxicol. Appl. Pharmacol. | pmid:4136643 |
| Gray JE et al. | Ultrastructural studies of the hepatic changes brought about by Clindamycin and Erythromycin in animals. | 1971 | Toxicol. Appl. Pharmacol. | pmid:4328315 |
| Iwamoto HK and Brennan WR | The effect of demeclocycline, methacycline, and erythromycin on tooth color in the rat. | 1969 | Toxicol. Appl. Pharmacol. | pmid:4975609 |
| Dujovne CA | Liver cell culture toxicity and surfactant potency of erythromycin derivatives. | 1975 | Toxicol. Appl. Pharmacol. | pmid:1135866 |
| Sadrieh N and Thomas PE | Characterization of rat cytochrome P450 isozymes involved in the covalent binding of cyclosporin A to microsomal proteins. | 1994 | Toxicol. Appl. Pharmacol. | pmid:8048065 |
| WORTH HM et al. | INTRAGASTRIC INJECTION FOR TOXICITY STUDIES WITH NEWBORN RATS. | 1963 | Toxicol. Appl. Pharmacol. | pmid:14082477 |
| Gray JE et al. | Foam cell response in the lung and lymphatic tissues during long-term high-level treatment with erythromycin. | 1978 | Toxicol. Appl. Pharmacol. | pmid:725925 |
| Kalsotra A et al. | Expression and characterization of human cytochrome P450 4F11: Putative role in the metabolism of therapeutic drugs and eicosanoids. | 2004 | Toxicol. Appl. Pharmacol. | pmid:15364545 |
| DeSalva SJ et al. | Lethal effects of antibiotics in hamsters. | 1969 | Toxicol. Appl. Pharmacol. | pmid:5787519 |
| Gaeta GB et al. | Characterization of the effects of erythromycin estolate and erythromycin base on the excretory function of the isolated rat liver. | 1985 | Toxicol. Appl. Pharmacol. | pmid:2992120 |
| Flaman AS et al. | The effect of interferon-α on the expression of cytochrome P450 3A4 in human hepatoma cells. | 2011 | Toxicol. Appl. Pharmacol. | pmid:21466820 |
| Hayashi S et al. | Characterization of multinuclear hepatocytes induced in rats by mitemcinal (GM-611), an erythromycin derivative. | 2008 | Toxicol Pathol | pmid:18776165 |
| Abdel-Hameid NA | Protective role of dimethyl diphenyl bicarboxylate (DDB) against erythromycin induced hepatotoxicity in male rats. | 2007 | Toxicol In Vitro | pmid:17267170 |
| Tilmant K et al. | Comparison of a genomic and a multiplex cell imaging approach for the detection of phospholipidosis. | 2011 | Toxicol In Vitro | pmid:21515356 |
| Peyre L et al. | High-content screening imaging and real-time cellular impedance monitoring for the assessment of chemical's bio-activation with regards hepatotoxicity. | 2015 | Toxicol In Vitro | pmid:26239606 |
| BARDIER A et al. | [Results of infantile propiocine granulated for syrup in infections pathology in infants (Apropos of 71 cases)]. | 1961 | Toulouse Med | pmid:13686911 |
| BARDIER A et al. | [CURRENT TREATMENT OF PLEURO-PULMONARY STAPHYLOCOCCAL INFECTIONS IN INFANTS (APROPOS OF 60 CASES)]. | 1964 | Toulouse Med | pmid:14169371 |
| DUBRA F | [PATHOLOGY OF PULMONARY TUBERCULOSIS CAUSED BY RESISTANT BACTERIA]. | 1963 Sep-Dec | Torax | pmid:14158172 |
| DUBRA F | [THE CURE OF PULMONARY TUBERCULOSIS CAUSED BY RESISTANT BACTERIA]. | 1963 Sep-Dec | Torax | pmid:14158173 |
| PALERMO FM | [SECONDARY BACTERIAL RESISTANCE]. | 1963 Sep-Dec | Torax | pmid:14159781 |
| Giuliano MW and Miller SJ | Site-Selective Reactions with Peptide-Based Catalysts. | 2016 | Top Curr Chem | pmid:26307403 |
| MUNOZBLAZQUEZ J | [ANTIBIOTIC-CORTISONE TREATMENT OF GENITAL INFLAMMATION]. | 1964 | Tokoginecol Pract | pmid:14108914 |
| Hara T et al. | Successful treatment of severe reflux esophagitis with erythromycin in a patient with progressive systemic sclerosis and proximal gastrectomy. | 2006 | Tokai J. Exp. Clin. Med. | pmid:21302226 |
| Partiarca PA et al. | Outbreaks of pertussis in the United States: the Wisconsin experience. | 1988 | Tokai J. Exp. Clin. Med. | pmid:3273611 |
| Onodera T et al. | Effect of fluid and antibiotic administration on experimental fecal peritonitis. | 1968 | Tohoku J. Exp. Med. | pmid:5715596 |
| Kanemitsu K et al. | Efficacy of amikacin combinations for nocardiosis. | 2003 | Tohoku J. Exp. Med. | pmid:14649737 |
| Ramos CJ and Antonetti DA | The role of small GTPases and EPAC-Rap signaling in the regulation of the blood-brain and blood-retinal barriers. | 2017 | Tissue Barriers | pmid:28632993 |
| van der Kuy A et al. | [The erythromycin group]. | 1974 | Tijdschr Ziekenverpl | pmid:4499128 |
| van der Lely N et al. | [A child with Chlamydia trachomatis pneumonia]. | 1993 | Tijdschr Kindergeneeskd | pmid:8266317 |
| Schurgers M et al. | [A case of toxic hepatitis]. | 1974 | Tijdschr Gastroenterol | pmid:4454054 |
| Devriese L | [Antibiotic sensitivity tests (author's transl)]. | 1976 | Tijdschr Diergeneeskd | pmid:827819 |
| Boswinkel M and Sloet van Oldruitenborgh-Oosterbaan MM | [Diagnosis and therapy of Rhodococcus equi infection in the horse]. | 2006 | Tijdschr Diergeneeskd | pmid:16989420 |
| van der Toorn F and Lumeij JT | [Streptococcus gallolyticus infections in racing pigeons, a literature review]. | 2001 | Tijdschr Diergeneeskd | pmid:11227399 |
| Bergan T | [Erythromycin instead of tetracyclines to children]. | 1978 | Tidsskr. Nor. Laegeforen. | pmid:684704 |
| Høye S | An extraordinary tale of an ordinary case. | 2015 | Tidsskr. Nor. Laegeforen. | pmid:26130550 |
| Loose LM et al. | Adolescent with respiratory impairments and short-lived fever. | 2015 | Tidsskr. Nor. Laegeforen. | pmid:26130549 |
| Lind O and Harthug S | [Hearing loss after erythromycin therapy]. | 1993 | Tidsskr. Nor. Laegeforen. | pmid:8211901 |
| Aas K | [Treatment of infections in allergic patients]. | 1974 | Tidsskr. Nor. Laegeforen. | pmid:4820866 |
| Lefsaker L et al. | [Legionnaires' disease]. | 1988 | Tidsskr. Nor. Laegeforen. | pmid:3353900 |
| Holst-Larsen L | [Antibacterial agents. 4. Erythromycin]. | 1972 | Tidsskr. Nor. Laegeforen. | pmid:4657026 |
| Hassel B | [Acute hypothermia and adverse effects on the central nervous system during erythromycin therapy]. | 1994 | Tidsskr. Nor. Laegeforen. | pmid:7915859 |